These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22972647)

  • 1. Brain MRI markers and dropout in a longitudinal study of cognitive aging: the Three-City Dijon Study.
    Glymour MM; Chêne G; Tzourio C; Dufouil C
    Neurology; 2012 Sep; 79(13):1340-8. PubMed ID: 22972647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological Test Performance and MRI Markers of Dementia Risk: Reducing Education Bias.
    Walter S; Dufouil C; Gross AL; Jones RN; Mungas D; Filshtein TJ; Manly JJ; Arpawong TE; Glymour MM
    Alzheimer Dis Assoc Disord; 2019; 33(3):179-185. PubMed ID: 31206372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of data from magnetic resonance imaging to improve prediction of dementia: population based cohort study.
    Stephan BC; Tzourio C; Auriacombe S; Amieva H; Dufouil C; Alpérovitch A; Kurth T
    BMJ; 2015 Jun; 350():h2863. PubMed ID: 26099688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of white-matter lesions with brain atrophy markers: the three-city Dijon MRI study.
    Godin O; Maillard P; Crivello F; Alpérovitch A; Mazoyer B; Tzourio C; Dufouil C
    Cerebrovasc Dis; 2009; 28(2):177-84. PubMed ID: 19556771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Joint effect of white matter lesions and hippocampal volumes on severity of cognitive decline: the 3C-Dijon MRI study.
    Godin O; Tzourio C; Rouaud O; Zhu Y; Maillard P; Pasquier F; Crivello F; Alpérovitch A; Mazoyer B; Dufouil C
    J Alzheimers Dis; 2010; 20(2):453-63. PubMed ID: 20164560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change.
    Vemuri P; Wiste HJ; Weigand SD; Shaw LM; Trojanowski JQ; Weiner MW; Knopman DS; Petersen RC; Jack CR;
    Neurology; 2009 Jul; 73(4):294-301. PubMed ID: 19636049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain structure and cerebrovascular risk in cognitively impaired patients: Shanghai Community Brain Health Initiative-pilot phase.
    He J; Iosif AM; Lee DY; Martinez O; Chu S; Carmichael O; Mortimer JA; Zhao Q; Ding D; Guo Q; Galasko D; Salmon DP; Dai Q; Wu Y; Petersen RC; Hong Z; Borenstein AR; DeCarli C
    Arch Neurol; 2010 Oct; 67(10):1231-7. PubMed ID: 20937951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people.
    den Heijer T; Geerlings MI; Hoebeek FE; Hofman A; Koudstaal PJ; Breteler MM
    Arch Gen Psychiatry; 2006 Jan; 63(1):57-62. PubMed ID: 16389197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Motoric Cognitive Risk Syndrome With Brain Volumes: Results From the GAIT Study.
    Beauchet O; Allali G; Annweiler C; Verghese J
    J Gerontol A Biol Sci Med Sci; 2016 Aug; 71(8):1081-8. PubMed ID: 26946101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal neuroimaging correlates of subjective memory impairment: 4-year prospective community study.
    Stewart R; Godin O; Crivello F; Maillard P; Mazoyer B; Tzourio C; Dufouil C
    Br J Psychiatry; 2011 Mar; 198(3):199-205. PubMed ID: 21357878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal volume and white matter disease in the prediction of dementia in Parkinson's disease.
    Kandiah N; Zainal NH; Narasimhalu K; Chander RJ; Ng A; Mak E; Au WL; Sitoh YY; Nadkarni N; Tan LC
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1203-8. PubMed ID: 25258331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White Matter Lesions are Associated with Specific Depressive Symptom Trajectories among Incident Depression and Dementia Populations: Three-City Dijon MRI Study.
    Tully PJ; Debette S; Mazoyer B; Tzourio C
    Am J Geriatr Psychiatry; 2017 Dec; 25(12):1311-1321. PubMed ID: 28688824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attrition and bias in the MRC cognitive function and ageing study: an epidemiological investigation.
    Matthews FE; Chatfield M; Freeman C; McCracken C; Brayne C;
    BMC Public Health; 2004 Apr; 4():12. PubMed ID: 15113437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accounting for bias due to selective attrition: the example of smoking and cognitive decline.
    Weuve J; Tchetgen Tchetgen EJ; Glymour MM; Beck TL; Aggarwal NT; Wilson RS; Evans DA; Mendes de Leon CF
    Epidemiology; 2012 Jan; 23(1):119-28. PubMed ID: 21989136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal volumetric MRI change and rate of cognitive decline.
    Mungas D; Harvey D; Reed BR; Jagust WJ; DeCarli C; Beckett L; Mack WJ; Kramer JH; Weiner MW; Schuff N; Chui HC
    Neurology; 2005 Aug; 65(4):565-71. PubMed ID: 16116117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.
    Smith EE; Egorova S; Blacker D; Killiany RJ; Muzikansky A; Dickerson BC; Tanzi RE; Albert MS; Greenberg SM; Guttmann CR
    Arch Neurol; 2008 Jan; 65(1):94-100. PubMed ID: 18195145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal magnetic resonance imaging vascular changes, apolipoprotein E genotype, and development of dementia in the neurocognitive outcomes of depression in the elderly study.
    Steffens DC; Potter GG; McQuoid DR; MacFall JR; Payne ME; Burke JR; Plassman BL; Welsh-Bohmer KA
    Am J Geriatr Psychiatry; 2007 Oct; 15(10):839-49. PubMed ID: 17623814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts.
    Farias ST; Mungas D; Reed BR; Harvey D; DeCarli C
    Arch Neurol; 2009 Sep; 66(9):1151-7. PubMed ID: 19752306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uric acid and incident dementia over 12 years of follow-up: a population-based cohort study.
    Latourte A; Soumaré A; Bardin T; Perez-Ruiz F; Debette S; Richette P
    Ann Rheum Dis; 2018 Mar; 77(3):328-335. PubMed ID: 28754803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.